Treatment with oral ubrogepant (Ubrelvy) during the migraine prodrome led to more patients being able to function normally, a prespecified secondary endpoint analysis of the phase III PRODROME trial ...
BARCELONA — For the first time, new research shows that taking a specific class of migraine medication during the prodromal phase reduces the development and severity of the subsequent headache. In ...
Ubrogepant is beneficial for the treatment of migraine when taken during the prodrome, according to a study published online Nov. 15 in The Lancet. David W. Dodick, M.D., from the Mayo Clinic in ...
- More patients treated with UBRELVY ® 100 mg during the prodrome avoided the development of moderate or severe headache within 24 hours post-dose vs. placebo in those who could identify prodrome ...
Share on Pinterest Taken at onset, ubrogepant may stop migraine attacks in their tracks. Image credit: Guido Mieth/Getty Images. Migraine attacks are painful events that can cause many unpleasant ...
A population-based study drew a possible connection between gastrointestinal (GI) symptoms and the multiple sclerosis (MS) prodrome. Patients with multiple sclerosis (MS) endure higher rates of drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results